X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
http://www.pharmatimes.com/news/shionogis_novel_antibiotic_added_to_uks_pilot_subscription_reimbursement_model_1360487
http://www.pharmatimes.com/news/shionogis_novel_antibiotic_added_to_uks_pilot_subscription_reimbursement_model_1360487
http://www.pharmafile.com/news/566949/shionogis-novel-antibiotic-selected-uk-pilot-subscription-reimbursement-model
https://www.businesswire.com/news/home/20201019005858/en/Shionogi-to-Present-New-Data-on-FETROJA%C2%AE-cefiderocol-at-IDWeek-2020
https://www.raps.org/news-and-articles/news-articles/2020/9/fda-roundup-nucala-fetroja-xeljanz
http://www.pharmatimes.com/news/shionogi_launches_novel_antibiotic_fetcroja_in_the_uk_1350296
https://www.businesswire.com/news/home/20200903005678/en/Shionogi-Granted-New-Technology-Add-on-Payment-FETROJA%C2%AE#:~:text=OSAKA%2C%20Japan%20and%20FLORHAM%20PARK,in%20the%20hospital%20inpatient%20setting.
https://www.ema.europa.eu/en/documents/overview/fetcroja-epar-medicine-overview_en.pdf
http://www.pharmatimes.com/news/ec_approves_shionogis_new_antibiotic_fetcroja_1339148
https://www.businesswire.com/news/home/20200302005439/en/Shionogi-Receives-Positive-CHMP-Opinion-FETCROJA%C2%AE-cefiderocol
https://www.raps.org/news-and-articles/news-articles/2020/2/chmp-recommends-one-new-drug-begins-review-of-ind
https://www.biospectrumasia.com/news/25/14966/shionogi-receives-fda-approval-for-cuti-drug-.html
https://endpts.com/despite-worries-triggered-by-imbalance-of-deaths-shionogis-antibiotic-clears-fda-panel-vote/
Market Place
Share 
